59512-17-3,
2-(4-isobutylphenyl)propanamide,
Ibuprofenamide,
2-[4-(2-methylpropyl)phenyl]propanamide,
(2RS)-2-[4-(2-Methylpropyl)phenyl]propanamide,
Benzeneacetamide, a-methyl-4-(2-methylpropyl)-,
2-(4-Isobutylphenyl)propionamide,
2-[4-(Isobutyl)phenyl]propionamide,
EINECS 261-793-9,
Ibuprofen Impurity C,
Maybridge1_008183,
RAC-IBUPROFEN AMIDE,
AC1L2Q1L,
AC1Q5IT5,
Cambridge id 5106625,
SCHEMBL260688,
NIOSH/UE4469300,
2-(p-Isobutylphenyl)propionamide,
CTK5B0071,
HMS564L21,
REUQKCDCQVNKLW-UHFFFAOYSA-N,
ZX-AT010719,
2-(4-isobutyl-phenyl)-propionamide,
2-(4-Isobutylphenyl)propanoic amide,
CCG-53179,
MFCD00454181,
OR0554,
Propionamide, 2-(p-isobutylphenyl)-,
STL308361,
4-isobutyl-alpha-methylphenylacetamide,
AKOS022099909,
MCULE-7082233294,
LS-124239,
UE44693000,
Benzeneacetamide, alpha-methyl-4-(2-methylpropyl)-,
SR-01000642360-1,
BRD-A57554269-001-01-9,
(2RS)-2-(4-Isobutylphenyl)propionamide, pharmaceutical impurity standard,
Ibuprofen amide,
UNII-74M0104F2J,
C13H19NO,
C13-H19-N-O,
AR-1C7870,
CID101072,
74M0104F2J,
CS-O-05861,
UE4469300,
61176-67-8,